Chemical Compound Background 9 masthead

Director/PDMR Dealing

Posted date: February 20, 2023

Download Full Message Here

20 February 2023

Iofina plc

(“Iofina” or the “Company“)

(AIM: IOF) 

Director/PDMR Dealing

Iofina plc (AIM: IOF) announces that it received notification on 17 February 2023 that Lance Baller, Non-Executive Chairman of the Company, purchased 50,000 ordinary shares in the capital of the Company at a price of 31 pence per share. Further details are set out in the notification of dealing form below.

Following the purchase, Mr. Baller holds 5,550,000 ordinary shares, representing approximately 2.89 per cent. of the Company’s issued share capital. The shares purchased represent approximately 0.03 per cent. of the Company’s issued share capital.

Director/PDMR Ordinary shares purchased Resultant interest in ordinary shares Resultant percentage of issued ordinary shares
Non-Executive Chairman 50,000 5,550,000 2.89%

This notification relates to transactions notified in accordance with Article 19 of the UK Market Abuse Regulation.

Enquiries:

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +1 859 356 8000

Nomad & Broker:

Henry Fitzgerald-O’Connor/Patrick Dolaghan/Andrew Potts

Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

Financial Adviser:

Kingsley Wilson

Chrystal Capital Partners LLP

Tel: +44 (0)20 7850 4761

Media Contact:

Charles Goodwin/Shivantha Thambirajah/Jazmine Clemens

Yellow Jersey PR Limited

Tel: +44 (0)7747 788 221/+44 (0)7983 521 488

iofina.com

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the persons discharging managerial responsibilities / person closely associated

 

a) Name Lance Baller
2

Reason for the notification

 

a) Position/Status Director
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Iofina plc
b) LEI 213800QDMFYVRJYYTQ84
4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial

instrument, type of

instrument

Identification code

Ordinary shares of £0.01 each

GB00B2QL5C79

b) Nature of the transaction Purchase of ordinary shares
c) Price(s) and volume(s)
Price(s) Volume(s)
31p 50,000
d)

Aggregated information

–     Aggregated volume

–     Price

50,000

31p

e) Date of transaction 17 February 2023
f) Place of transaction London Stock Exchange, AIM Market (XLON)
Previous ArticleTrading Update, FY 2022 EBITDA expected to exceed market expectations Next ArticleQ1 2023 Corporate Update
Translate »